Indian Air Force Medicines Tender 2026 – Critical Care Drugs & Pharmaceuticals Procurement India with 25% Quantity Flexibility

Bidders must submit GSTIN, PAN, experience proofs for similar medical supply, financial statements, technical bid, and OEM authorizations. The tender allows up to 25% quantity variation and requires compliance with general government procurement norms. Prepare delivery capabilities and warranty terms where applicable, and ensure product range aligns with listed drug categories.

Required documents include GST certificate, PAN card, prior experience certificates, financial statements, evidence of EMD submission if applicable, technical bid detailing product list, OEM authorization for each brand, and distribution licenses. Ensure items cover antibiotics, antivirals, analgesics, sedatives, and supportive care drugs as listed.

No item-level specifications are provided; bidders should confirm product composition, dosage forms, packaging sizes, and regulatory approvals. Align submissions with standard pharmaceutical regulatory requirements and include product registration or approvals where necessary for all listed medicines.

Delivery timelines depend on the original delivery order and are adjustable via the option clause. The calculated additional delivery time uses (additional quantity ÷ original quantity) × original delivery period, with a minimum 30 days, and the purchaser may extend this window within contracted rates.

The purchaser may increase or decrease quantity up to 25% at contract award and again during the contract currency, at contracted rates. Delivery schedules adapt based on last delivery order date, ensuring continuity of supply while maintaining price stability.

Eligibility requires demonstrated government or large-institution pharmaceutical supply experience, valid GST and PAN, robust financials, and tender-specific qualifications such as OEM authorizations and technical bid readiness. Compliance with general procurement norms is essential for bid submission.

The BoQ lists 42 items spanning analgesics, anti-infectives, sedatives, cardiovascular drugs, antiseptics, vitamins, and supportive therapies. While item-level quantities are not shown, ensure a broad product catalog matching the listed drug categories and maintain regulatory compliance for each item.

Payment terms are not explicitly provided in the document. Bidders should anticipate standard government terms (e.g., payment upon delivery or after acceptance) and confirm EMD requirements, invoicing procedures, and potential advance or milestone payments during bid submission.